0 followers
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
157 followers
Regeneron
124 followers
Illumina
78 followers
Agilent Technologies
78 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
44 followers
Explore companies